Biotechnology firm Biogen Idec Inc said on Friday it was exploring a possible sale of the company and has already interest from billionaire investor Carl Icahn, who has recently bought up company shares.
The Cambridge, Massachusetts-based maker of drugs to treat conditions including multiple sclerosis and arthritis said its board had authorized management to explore a possible sale, although it cautioned that there was no assurance a deal would occur.
The company's market capital is just shy of US$20 billion.
STRATEGIC INTEREST
The company issued a statement saying its current business strategy "is working and generating strong operating and financial performance ... Nevertheless, to determine whether potential strategic interest on the part of major pharmaceutical companies might result in superior value in the current environment, the board has authorized management to explore interest in a transaction with Biogen Idec."
Biogen Idec said it has received "expressions of interest, including one from investor Carl Icahn."
The company said it would not disclose further information until its evaluation was complete.
CLEARED
In August, federal antitrust regulators cleared Icahn to buy a stake in Biogen Idec.
Earlier in the month, Icahn reported purchasing 2.7 million shares of the company as of June 30.
Biogen Idec retained Goldman Sachs & Co and Merrill Lynch & Co to assist in the review of a possible sale.
The company, founded in 1978, is due to report third-quarter earnings on Oct. 23.
In July, the company said it swung to a second-quarter profit on strong sales of two key drugs, the MS drug Avonex and Rituxan, approved for non-Hodgkin's lymphoma and rheumatoid arthritis.
Quanta Computer Inc (廣達) chairman Barry Lam (林百里) is expected to share his views about the artificial intelligence (AI) industry’s prospects during his speech at the company’s 37th anniversary ceremony, as AI servers have become a new growth engine for the equipment manufacturing service provider. Lam’s speech is much anticipated, as Quanta has risen as one of the world’s major AI server suppliers. The company reported a 30 percent year-on-year growth in consolidated revenue to NT$1.41 trillion (US$43.35 billion) last year, thanks to fast-growing demand for servers, especially those with AI capabilities. The company told investors in November last year that
Intel Corp has named Tasha Chuang (莊蓓瑜) to lead Intel Taiwan in a bid to reinforce relations between the company and its Taiwanese partners. The appointment of Chuang as general manager for Intel Taiwan takes effect on Thursday, the firm said in a statement yesterday. Chuang is to lead her team in Taiwan to pursue product development and sales growth in an effort to reinforce the company’s ties with its partners and clients, Intel said. Chuang was previously in charge of managing Intel’s ties with leading Taiwanese PC brand Asustek Computer Inc (華碩), which included helping Asustek strengthen its global businesses, the company
Taiwanese suppliers to Taiwan Semiconductor Manufacturing Co. (TSMC, 台積電) are expected to follow the contract chipmaker’s step to invest in the US, but their relocation may be seven to eight years away, Minister of Economic Affairs J.W. Kuo (郭智輝) said yesterday. When asked by opposition Chinese Nationalist Party (KMT) Legislator Niu Hsu-ting (牛煦庭) in the legislature about growing concerns that TSMC’s huge investments in the US will prompt its suppliers to follow suit, Kuo said based on the chipmaker’s current limited production volume, it is unlikely to lead its supply chain to go there for now. “Unless TSMC completes its planned six
TikTok abounds with viral videos accusing prestigious brands of secretly manufacturing luxury goods in China so they can be sold at cut prices. However, while these “revelations” are spurious, behind them lurks a well-oiled machine for selling counterfeit goods that is making the most of the confusion surrounding trade tariffs. Chinese content creators who portray themselves as workers or subcontractors in the luxury goods business claim that Beijing has lifted confidentiality clauses on local subcontractors as a way to respond to the huge hike in customs duties imposed on China by US President Donald Trump. They say this Chinese decision, of which Agence